145 related articles for article (PubMed ID: 31773154)
1. Incidence, prognostic impact and clinical outcomes of renal impairment in patients with multiple myeloma: a population-based registry.
Courant M; Orazio S; Monnereau A; Preterre J; Combe C; Rigothier C
Nephrol Dial Transplant; 2021 Feb; 36(3):482-490. PubMed ID: 31773154
[TBL] [Abstract][Full Text] [Related]
2. Renal Impairment at Diagnosis in Myeloma: Patient Characteristics, Treatment, and Impact on Outcomes. Results From the Australia and New Zealand Myeloma and Related Diseases Registry.
Ho PJ; Moore EM; McQuilten ZK; Wellard C; Bergin K; Augustson B; Blacklock H; Harrison SJ; Horvath N; King T; Mollee P; Quach H; Reid C; Rosengarten B; Walker P; Wood EM; Spencer A
Clin Lymphoma Myeloma Leuk; 2019 Aug; 19(8):e415-e424. PubMed ID: 31208889
[TBL] [Abstract][Full Text] [Related]
3. Severe renal impairment as an adverse prognostic factor for survival in newly diagnosed multiple myeloma patients.
Chen X; Luo X; Zu Y; Issa HA; Li L; Ye H; Yang T; Hu J; Wei L
J Clin Lab Anal; 2020 Sep; 34(9):e23416. PubMed ID: 32710448
[TBL] [Abstract][Full Text] [Related]
4. Impact of renal impairment on outcomes after autologous stem cell transplantation in multiple myeloma: a multi-center, retrospective cohort study.
Antlanger M; Dust T; Reiter T; Böhm A; Lamm WW; Gornicec M; Willenbacher E; Nachbaur D; Weger R; Rabitsch W; Rasoul-Rockenschaub S; Worel N; Lechner D; Greinix H; Keil F; Gisslinger H; Agis H; Krauth MT
BMC Cancer; 2018 Oct; 18(1):1008. PubMed ID: 30342509
[TBL] [Abstract][Full Text] [Related]
5. Response and Dynamics of Renal Function in Transplantation-Eligible Multiple Myeloma Patients Treated with a Novel Agent: The CAREMM-2201 Study.
Kim Y; Park SS; Jeon YW; Yahng SA; Shin SH; Min CK;
Transplant Cell Ther; 2023 Jan; 29(1):55.e1-55.e9. PubMed ID: 36202336
[TBL] [Abstract][Full Text] [Related]
6. Renal impairment is not an independent adverse prognostic factor in patients with multiple myeloma treated upfront with novel agent-based regimens.
Eleftherakis-Papapiakovou E; Kastritis E; Roussou M; Gkotzamanidou M; Grapsa I; Psimenou E; Nikitas N; Terpos E; Dimopoulos MA
Leuk Lymphoma; 2011 Dec; 52(12):2299-303. PubMed ID: 22141916
[TBL] [Abstract][Full Text] [Related]
7. Lack of Renal Recovery Predicts Poor Survival in Patients of Multiple Myeloma With Renal Impairment.
Sharma R; Jain A; Jandial A; Lad D; Khadwal A; Prakash G; Nada R; Aggarwal R; Ramachandran R; Varma N; Malhotra P
Clin Lymphoma Myeloma Leuk; 2022 Aug; 22(8):626-634. PubMed ID: 35610119
[TBL] [Abstract][Full Text] [Related]
8. Significant improvement in the survival of patients with multiple myeloma presenting with severe renal impairment after the introduction of novel agents.
Dimopoulos MA; Delimpasi S; Katodritou E; Vassou A; Kyrtsonis MC; Repousis P; Kartasis Z; Parcharidou A; Michael M; Michalis E; Gika D; Symeonidis A; Pouli A; Konstantopoulos K; Terpos E; Kastritis E
Ann Oncol; 2014 Jan; 25(1):195-200. PubMed ID: 24356630
[TBL] [Abstract][Full Text] [Related]
9. Renal Insufficiency in newly-diagnosed multiple myeloma: analysis according to International Myeloma Working Group consensus statement.
Park S; Han B; Kim K; Kim SJ; Jang JH; Kim WS; Jung CW
Anticancer Res; 2014 Aug; 34(8):4299-306. PubMed ID: 25075062
[TBL] [Abstract][Full Text] [Related]
10. The use of novel drugs can effectively improve response, delay relapse and enhance overall survival in multiple myeloma patients with renal impairment.
Uttervall K; Duru AD; Lund J; Liwing J; Gahrton G; Holmberg E; Aschan J; Alici E; Nahi H
PLoS One; 2014; 9(7):e101819. PubMed ID: 25003848
[TBL] [Abstract][Full Text] [Related]
11. Current Trends of Renal Impairment in Multiple Myeloma.
Yadav P; Cook M; Cockwell P
Kidney Dis (Basel); 2016 Mar; 1(4):241-57. PubMed ID: 27536684
[TBL] [Abstract][Full Text] [Related]
12. Improvement in renal function and its impact on survival in patients with newly diagnosed multiple myeloma.
Gonsalves WI; Leung N; Rajkumar SV; Dispenzieri A; Lacy MQ; Hayman SR; Buadi FK; Dingli D; Kapoor P; Go RS; Lin Y; Russell SJ; Lust JA; Zeldenrust S; Kyle RA; Gertz MA; Kumar SK
Blood Cancer J; 2015 Mar; 5(3):e296. PubMed ID: 25794132
[TBL] [Abstract][Full Text] [Related]
13. Current treatments for renal failure due to multiple myeloma.
Gavriatopoulou M; Terpos E; Kastritis E; Dimopoulos MA
Expert Opin Pharmacother; 2016 Nov; 17(16):2165-2177. PubMed ID: 27646819
[TBL] [Abstract][Full Text] [Related]
14. Trends in Survival and Renal Recovery in Patients with Multiple Myeloma or Light-Chain Amyloidosis on Chronic Dialysis.
Decourt A; Gondouin B; Delaroziere JC; Brunet P; Sallée M; Burtey S; Dussol B; Ivanov V; Costello R; Couchoud C; Jourde-Chiche N
Clin J Am Soc Nephrol; 2016 Mar; 11(3):431-41. PubMed ID: 26728585
[TBL] [Abstract][Full Text] [Related]
15. Association between serum erythropoietin levels and renal reversibility in patients with renal impairment from multiple myeloma.
Kobayashi H; Terao T; Tsushima T; Abe Y; Miura D; Narita K; Kitadate A; Takeuchi M; Matsue K
Cancer Med; 2020 Jun; 9(12):4460-4466. PubMed ID: 32311841
[TBL] [Abstract][Full Text] [Related]
16. Negative Impact of Borderline Creatinine Concentration and Glomerular Filtration Rate at Baseline on the Outcome of Patients With Multiple Myeloma Treated With Autologous Stem Cell Transplant.
Waszczuk-Gajda A; Małyszko J; Vesole DH; Feliksbrot-Bratosiewicz M; Skwierawska K; Krzanowska K; Kobylińska K; Biecek P; Snarski E; Rodziewicz-Lurzyńska A; Kozłowski P; Stefaniak A; Drozd-Sokołowska J; Ziarkiewicz M; Vyas P; Boguradzki P; Mądry K; Biliński J; Tomaszewska A; Maciejewska M; Urbanowska E; Blajer B; Król M; Król M; Zborowska H; Jurczyszyn A; Dwilewicz-Trojaczek J; Jedrzejczak WW; Basak GW
Transplant Proc; 2020 Sep; 52(7):2186-2192. PubMed ID: 32222395
[TBL] [Abstract][Full Text] [Related]
17. The impact of age and comorbidities on practice patterns and outcomes in patients with relapsed/refractory multiple myeloma in the era of novel therapies.
Hari P; Romanus D; Luptakova K; Blazer M; Yong C; Raju A; Farrelly E; Labotka R; Morrison VA
J Geriatr Oncol; 2018 Mar; 9(2):138-144. PubMed ID: 29056336
[TBL] [Abstract][Full Text] [Related]
18. Renal impairment after spontaneous bacterial peritonitis: incidence and prognosis.
Perdomo Coral G; Alves de Mattos A
Can J Gastroenterol; 2003 Mar; 17(3):187-90. PubMed ID: 12677269
[TBL] [Abstract][Full Text] [Related]
19. [Clinical analysis of newly diagnosed multiple myeloma patients with renal dysfunction].
Zhu W; Lu J; Lu J; Hou J; Huang X; Chen W
Zhonghua Yi Xue Za Zhi; 2015 Mar; 95(10):741-4. PubMed ID: 26080844
[TBL] [Abstract][Full Text] [Related]
20. From guidelines to real world: results from the National Multiple Myeloma Registry in Uruguay on 222 newly diagnosed multiple myeloma patients from 2012 to 2015.
Riva E; Bove V; Villano F; Mori M; Córdoba C; Noria A; Petruskevicius P; Cardeza A; Díaz L
Curr Med Res Opin; 2019 Jul; 35(7):1197-1203. PubMed ID: 30621522
[No Abstract] [Full Text] [Related]
[Next] [New Search]
